retatrutide dosage calculator for weight loss female Retatrutide: The New Triple-Agonist Weight

According to the available timelines, the phase 3 clinical trial is expected to conclude in early 2026 with potential FDA approval in 2027

For patients with diabetes, dehydration poses additional risks by potentially affecting kidney function and blood glucose stability

Patients wishing to understand their eligibility for NHS weight management services, including Tier 3 specialist services or Tier 4 bariatric surgery pathways, should speak to their GP, who can advise on local referral criteria in line with NICE and NHS guidance

Gastroenterology 150 , 454464.e9 (2016)

When your BMI drops below 27 Once you drop below the licensed threshold (BMI 27, or 24.5 if youre using the ethnic-adjusted threshold), policies vary widely